Universitätsklinikum Düsseldorf

Aktueller Stand der Durchführung von Nierenersatztherapien auf deutschen Intensivstationen (2021) Willam C, Meersch M, Herbst L, Heering P, Schmitz M, Oppert M, John S, et al. Journal article AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 (2021) Ditsch N, Kolberg-Liedtke C, Friedrich M, Jackisch C, Albert US, Banys-Paluchowski M, Bauerfeind I, et al. Journal article, Review article AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 (2021) Thill M, Friedrich M, Kolberg-Liedtke C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, et al. Journal article, Review article Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study (2021) Saxena M, Schmieder R, Kirtane AJ, Mahfoud F, Daemen J, Basile J, Lurz P, et al. Journal article Correction to: Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group (Strahlentherapie und Onkologie, (2021), 10.1007/s00066-020-01727-4) (2021) Ostheimer C, Maeurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, et al. Journal article, Erratum Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer (2021) Lüftner D, Hartkopf AD, Lux MP, Overkamp F, Tesch H, Titzmann A, Pöschke P, et al. Journal article, Review article Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study (2021) Prieske K, Woelber L, Muallem MZ, Eulenburg C, Jueckstock JK, Hilpert F, de Gregorio N, et al. Journal article Auswirkungen der SARS-CoV‑2-Pandemie auf die universitäre Hals-Nasen-Ohren-Heilkunde im Bereich der Forschung, Lehre und Weiterbildung (2021) Stöver T, Dazert S, Plontke SK, Kramer S, Ambrosch P, Arens C, Betz C, et al. Journal article Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward (2021) Krug D, Baumann R, Combs SE, Duma MN, Dunst J, Feyer P, Fietkau R, et al. Journal article, Review article Corrigendum to “Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany” (The Breast (2020) 54 (88–95), (S0960977620301648), (10.1016/j.breast.2020.08.011)) (2021) Schneeweiss A, Ettl J, Lüftner D, Beckmann M, Belleville E, Fasching P, Fehm TN, et al. Journal article, Erratum